- 2024-08-20 01:54抑制剂DUPA(OtBu)-OH|DUPA(OtBu)-OH|1026987-94-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Dynarrestin|Dynarrestin|2222768-84-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂DUB-IN-3|DUB-IN-3|924296-17-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂DUB-IN-3|DUB-IN-3|924296-17-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂DUB-IN-3|DUB-IN-3|924296-17-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂DUB-IN-1|DUB-IN-1|924296-18-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂DUB-IN-2|DUB-IN-2|924296-19-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂DUB-IN-2|DUB-IN-2|924296-19-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂DUB-IN-2|DUB-IN-2|924296-19-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂DSPE-PEG(2000)-Amine|DSPE-PEG(2000)-Amine|474922-26-4|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 01:54抑制剂DUB-IN-1|DUB-IN-1|924296-18-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂DUB-IN-1|DUB-IN-1|924296-18-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂DSPC|DSPC|816-94-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂DSPC|DSPC|816-94-4|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 01:54抑制剂DSPE-PEG(2000)-Amine|DSPE-PEG(2000)-Amine|474922-26-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂DSPE-PEG(2000)-Amine|DSPE-PEG(2000)-Amine|474922-26-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂DSP-2230|DSP-2230|1233231-30-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂DSP-2230|DSP-2230|1233231-30-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂DSP-2230|DSP-2230|1233231-30-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂DS-6051b|Taletrectinib|1505515-69-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
